MBAI
Check-Cap Ltd. Ordinary Share
There isn't enough reported data to score MBAI yet.
MBAI Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Unavailable |
MBAI's profitability is currently healthy. There isn't enough data to rate its revenue, cash flow and balance sheet.
MBAI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 0.5x | $2.09 | — |
| Cheap | 0.7x | $3.31 | +58% |
| Fair | 2.3x | $10.69 | +412% |
| Expensive | 38x | $177 | +8350% |
Historical ranges are pointers, not guarantees.
MBAI's PE is 0.5x, but its earnings don't support one, so it isn't a reliable read right now.
MBAI Forward outlook
There aren't enough analyst estimates for MBAI to show an outlook.
MBAI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2021 | -$4.20 | -106% |
| Q4 2020 | -$42.00 | -1100% |
| Q2 2020 | $70.00 | +2400% |
| Q4 2019 | $4.20 | +$126.00 |
MBAI's earnings per share have fallen from their peak: $4.62 over the past year, against $1,780.80 in late 2015.
MBAI Quarterly Revenue
MBAI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2023 | -$7.1M | +$1.4M |
| Q2 2023 | -$9.9M | +$762K |
| Q4 2022 | -$8.5M | +$727K |
| Q2 2022 | -$10.7M | -$2.7M |
| Q4 2021 | -$9.3M | -$2.3M |
| Q2 2021 | -$8M | -$1.5M |
| Q4 2020 | -$7M | -$366K |
| Q2 2020 | -$6.5M | -$116K |
MBAI has burned cash in almost every quarter: −$36M over the past year, against −$31M the year before.
MBAI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +6.5% | +54.5K shares |
| 1 year | +6.6% | +54.8K shares |
| 3 years | +4447% | +871K shares |
MBAI has 890,318 diluted shares, up 6.6% from a year ago.
MBAI Net Leverage
MBAI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.6 | Oversold |
| Stochastic | 5.4 | Oversold |
MBAI's weekly RSI is 30 (oversold) and its Stochastic is 5 (oversold).
MBAI PE vs Healthcare Sector
| Metric | MBAI | Sector median | Relative |
|---|---|---|---|
| PE | 0.5x | 26x | 98% below |
| PE % | 1 | 29 | 28 pts below |
MBAI is trading at 0.5x earnings, a 98% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
MBAI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.79 | 25% below |
| 20 week MA | $5.67 | 63% below |
| 50 week MA | $9.15 | 77% below |
| 100 week MA | $8.30 | 75% below |
| 200 week MA | $12.3 | 83% below |
MBAI is in a downtrend: it's below all five of its weekly moving averages, and 83% below its 200-week average.
MBAI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $245.0 | $54.0 | -78% |
| 2021 | $54.0 | $103.3 | +91% |
| 2022 | $103.3 | $14.8 | -86% |
| 2023 | $14.8 | $14.6 | -1.4% |
| 2024 | $14.6 | $7.70 | -47% |
| 2025 | $7.70 | $11.8 | +53% |
| 2026 YTD | $11.8 | $2.09 | -82% |
MBAI has finished lower in four of the last six years. It's down 82% so far in 2026.